|Bid||1.00 x 900|
|Ask||8.10 x 900|
|Day's range||7.47 - 7.87|
|52-week range||4.83 - 10.33|
|Beta (5Y monthly)||1.40|
|PE ratio (TTM)||60.38|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
This morning, we issued a press release providing a corporate update and financial results for the quarter ended March 31, 2021. As a reminder, before we begin, the following presentation includes several matters that constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those contemplated in such forward-looking statements.
A look at the shareholders of Avadel Pharmaceuticals plc ( NASDAQ:AVDL ) can tell us which group is most powerful...